Life sciences waiting on social media rules

Share this article:
The life sciences industry is sitting on the sidelines and waiting for regulatory guidance, rather than jumping into wide-scale use of social media, according to a Deloitte Research report.
The report said that part of the hesitation may be because the industry thinks of social networks as marketing, a more-targeted form of DTC advertising. However, it says, social networks are promising as tools that let a company collect information from, communicate to, and collaborate with people outside company walls.
Deloitte said its study described a framework for how social networks are being used today and in the future; explained how social networks add value beyond marketing but across the commercial and research organization; discussed survey data from industry professionals who are using or plan to use social networks; explored the accelerators and barriers to social networking use in the industry; identified when it is appropriate to use a social network and for what purpose; and examined the right governance and policy measures that should be in place.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"